Strs Ohio Fennec Pharmaceuticals Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$5.96 - $7.85 $92,380 - $121,675	-15,500 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$5.43 - $9.39 $84,165 - $145,545	15,500 New	15,500 $129,000
Q3 2019 Oct 21, 2019	SELL	$3.85 - $4.95 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$3.3 - $5.09 $10,890 - $16,797	-3,300 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$10.05 - $14.33 $33,165 - $47,289	3,300 New	3,300 $34,000

14.8M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $169M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.